510(k) Report

510(k) · Cleared

Cleared

Sperm-Select Additional Indication

K872849510(k) TraditionalCleared Sep 28, 198770-day reviewClass II21 CFR 884.5250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pharmacia, Inc. · HDR Cap, Cervical

Cleared on Sep 28, 1987 after a 70-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 5 later devices descend from it.

Decided
Sep 28, 1987
Review
70 days
Class
Class II
Product code
HDR
Recalls
None
Predicates
0

5 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 1997: 1 descendant cleared1998: 1 descendant cleared1999: 2 descendants cleared2002: 1 descendant cleared1990200020102020
  1. This deviceK872849 Sperm-Select Additional IndicationPharmacia, Inc. · 1987
  2. Descendant · cites it directly · 4 of its ownK971809 IsolateIrvine Scientific Sales Co., Inc. · 1997
  3. Descendant · 2 generations on · 1 of its ownK991341 Isolate, Isolate Concentrate, Isolate Stock SolutionIrvine Scientific Sales Co., Inc. · 1999 · Recalled
  4. Descendant · cites it directly · 1 of its ownK980814 PurespermNidacon International AB · 1998
  5. Descendant · 3 generations on · 0 of its ownK023403 Spermgrad, Models 10022/10063Vitrolife Sweden AB · 2002
  6. Descendant · 2 generations on · 0 of its ownK984172 Modification of PurespermNidacon International AB · 1999

Most influential descendants

Showing 5 of 5 · See all
  • K971809IsolateIrvine Scientific Sales Co., Inc. · 1997 · cites it directly4descendants
  • K991341Isolate, Isolate Concentrate, Isolate Stock SolutionIrvine Scientific Sales Co., Inc. · 1999 · 2 generations on1descendant
  • K980814PurespermNidacon International AB · 1998 · cites it directly1descendant
  • K023403Spermgrad, Models 10022/10063Vitrolife Sweden AB · 2002 · 3 generations on0descendants
  • K984172Modification of PurespermNidacon International AB · 1999 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K872849Sperm-Select Additional IndicationPharmacia, Inc.1987—
+1K971809IsolateIrvine Scientific Sales Co., Inc.1997—
+2K991341Isolate, Isolate Concentrate, Isolate Stock SolutionIrvine Scientific Sales Co., Inc.19991
+1K980814PurespermNidacon International AB1998—
+3K023403Spermgrad, Models 10022/10063Vitrolife Sweden AB2002—
+2K984172Modification of PurespermNidacon International AB1999—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199710
199810
199920
200210
FIG. 1 — Lineage of K872849, 1987–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HDR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HDR device

  1. #1 K242031 Béa Applicator (BAP-GB-01)score 9.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K971809IsolateIrvine Scientific Sales Co., Inc.19974
K980814PurespermNidacon International AB19981

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K971809 (Irvine Scientific Sales Co., Inc., 1997) has gone furthest, with 4 descendants of its own.

How does its category compare?

All HDR devices

HDR Cap, Cervical: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HDR

1in 2025

2023: 12025: 1
2007high 1 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HDR

Too few HDR 510(k)s in any year since 2007 to give a median.

Recalls per year · HDR

No recall names HDR since 2007.

Adverse event reports per year · HDR

1in 2014

2014: 1
2007high 1 (2014) · low 0 (2007)2025

MAUDE reports naming product code HDR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—01
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20240—00
20251—00
20260—0—
Cite this page

510(k) Report. “K872849: Sperm-Select Additional Indication.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K872849

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026